Imported vs. Domestic: The fight to protect Gulf seafood
Mississippi lawmakers are considering House Bill 602 and Senate Bill 2014, both designed to ensure consumers know whether ...
BioSpace7d
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
Keeping MS under control: New treatments finally bring hope to Floridians living with multiple sclerosis
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...
Managed Healthcare Executive7d
FDA Adds Boxed Warning to MS Drug Copaxone
Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
pharmaphorum1d
First Tysabri biosimilar cleared by FDA for MS
The FDA said the biosimilar, called Tyruko, has been approved to treat adults with relapsing forms of MS and active secondary progressive MS, as well as for certain patients with Crohn's disease ...
MedPage Today7d
FDA Warns About Anaphylaxis Risk With MS Drug
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
The American Journal of Managed Care7d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
pharmaphorum7d
Merck's oral MS drug finally gets FDA okay
as Mavenclad is only the second oral MS drug to be approved for this indication after Novartis’ brand new Mayzent (siponimod) which got a green light from the FDA last week. There’s more near ...